Nabi Junaid, Cone Eugene B, Vasavada Anjali, Sun Maxine, Kilbridge Kerry L, Kibel Adam S, Berry Donna L, Trinh Quoc-Dien
Division of Urological Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Center for Surgery and Public Health, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
JMIR Mhealth Uhealth. 2020 Nov 3;8(11):e20224. doi: 10.2196/20224.
Androgen deprivation therapy (ADT) increases the risk of metabolic adverse effects among patients with prostate cancer. The transformative impact of mobile health (mHealth) apps may benefit men managing activity and nutrition at home.
This study aimed to evaluate the usability and patient experience of a newly developed mHealth app among prostate cancer patients on ADT and physicians' beliefs about the potential benefits of using this app.
This study took place over 2 months, beginning in March 2019. A sample of 5 patients (age 45-75 years) initiating ADT participated in a semistructured focus group discussion with a facilitator. The study participants also included 5 specialist physicians who provided in-depth interviews. An institutional review board-approved script was used to guide both the focus group and physician interviews. Usability was tested through specific scenarios presented to the patients, including downloading the mHealth app, entering information on physical activity and meals, and navigating the app. The focus group and interviews were audio recorded and transcribed. Content analysis was used to analyze the transcripts iteratively and exhaustively. Thematic discrepancies between reviewers were resolved through consensus.
The mean age of the patients was 62 years. This group included 4 White and 1 Latin American patients. The physician specialists included 2 urologists, 2 medical oncologists, and 1 radiation oncologist. Analyses revealed that the patients appreciated the holistic care enabled by the app. Difficulties were observed with registration of the app among 60% (3/5) of the patients; however, all the patients were able to input information about their physical activity and navigate the options within the app. Most patients (4/5, 80%) were able to input data on their recent meal. Among the health care physicians, the dominant themes reflected in the interviews included undermining of patients ability to use technology, patients' fear of technology, and concern for the ability of older patients to access technology.
The patients reported an overall positive experience of using an mHealth app to record and track diet and exercise. Usability was observed to be an important factor for adoption and was determined by ease of registration and use, intuitive appearance of the app, and focus on holistic cancer care. The physicians believed that the app was easy to use but raised concerns about usability among older men who may not typically use smartphone apps.
雄激素剥夺疗法(ADT)会增加前列腺癌患者发生代谢不良反应的风险。移动健康(mHealth)应用程序的变革性影响可能会使在家中管理活动和营养的男性受益。
本研究旨在评估一款新开发的mHealth应用程序在接受ADT治疗的前列腺癌患者中的可用性和患者体验,以及医生对使用该应用程序潜在益处的看法。
本研究于2019年3月开始,为期2个月。5名开始接受ADT治疗的患者(年龄45 - 75岁)组成的样本在一名主持人的引导下参加了半结构化焦点小组讨论。研究参与者还包括5名提供深入访谈的专科医生。使用经机构审查委员会批准的脚本指导焦点小组讨论和医生访谈。通过向患者呈现的特定场景测试可用性,包括下载mHealth应用程序、输入身体活动和饮食信息以及在应用程序中导航。焦点小组讨论和访谈进行了录音和转录。使用内容分析法对转录本进行反复详尽分析。通过共识解决审阅者之间的主题差异。
患者的平均年龄为62岁。该组包括4名白人患者和1名拉丁裔患者。医生专家包括2名泌尿科医生、2名医学肿瘤学家和1名放射肿瘤学家。分析显示患者赞赏该应用程序提供的整体护理。60%(3/5)的患者在应用程序注册方面遇到困难;然而,所有患者都能够输入有关其身体活动的信息并在应用程序中进行操作。大多数患者(4/5,80%)能够输入近期饮食数据。在医疗保健医生中,访谈中反映的主要主题包括削弱患者使用技术的能力、患者对技术的恐惧以及对老年患者使用技术能力的担忧。
患者报告使用mHealth应用程序记录和跟踪饮食及运动的总体体验良好。可用性被认为是采用该应用程序的一个重要因素,其取决于注册和使用的便捷性、应用程序直观的外观以及对癌症整体护理的关注。医生认为该应用程序易于使用,但对可能不常使用智能手机应用程序的老年男性的可用性表示担忧。